Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,610 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma

NCT03224507

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States
  • University of Wisconsin, school of medicine and public health Madison, Wisconsin, United States
View Trial Details
Completed

BRAF/MEK Inhibition in Relapsed/Refractory Multiple Myeloma (BIRMA)

NCT02834364

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
Locations
  • Universitätsklinikum Köln, Klinik I Innere Medizin Cologne, Germany
  • Mediz. Klinik und Poliklinik 1, Universitätsklinikum Dresden Dresden, Germany
  • Universitätsklinikum Frankfurt, Medizinische Klinik II Frankfurt am Main, Germany
  • University Hospital Heidelberg, Med. Klinik V Heidelberg, Germany
View Trial Details
Completed

A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies

NCT02352558

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +30 more
Locations
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Indiana University Indianapolis, Indiana, United States
  • West Clinic Germantown, Tennessee, United States
  • Cancer Care Centers of South Texas San Antonio, Texas, United States
View Trial Details
Completed

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

NCT02639559

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +38 more
Locations
  • Northside Hospital Cancer Institute Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Ohio State University Columbus, Ohio, United States
View Trial Details
Completed

Study of bb21217 in Multiple Myeloma

NCT03274219

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • UCSF Medical Center at Parnassus San Francisco, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Insitute, Emory University Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details

Related conditions